Pursuant to a decision adopted at the annual general meeting 2013, 409,092 B shares have been cancelled during July 2013. The total number of shares and votes in the company has thus changed. On June 28, 2013, the total number of shares in the company amounted to 25,380,922, of which 1,289,832 were A shares and 24,091,090 were B shares. The total number of votes in the company amounted to 3,698,941.0. Pursuant to a decision adopted at the annual general meeting held on March 26, 2013 and following the decision by the Swedish Companies Registration Office (Bolagsverket), the share capital was reduced during July 2013 by 8,181,840 Swedish kronor through the cancellation of 409,092 B shares. This has resulted in a decrease in the number of B shares by 409,092 and a decrease in the total number of votes by 40,909.2. On July 31, 2013, the total number of shares in the company amounted to 24,971,830, of which 1,289,832 were A shares and 23,681,998 were B shares. The total number of votes in the company amounted to 3,658,031.8. On July 31, 2013, IFS held 200,000 B shares in own custody. About IFS IFS is a public company (XSTO: IFS) founded in 1983 that develops, supplies, and implements IFS Applications™, a component-based extended ERP suite. IFS focuses on industries where management of any of the following four core processes is strategic: service & asset, manufacturing, supply chain, and projects. The company has 2,000 customers and is present in approximately 60 countries with 2,800 employees in total. Net revenue in 2012 was SKr 2.7 billion. More information on IFS is available at www.IFSWORLD.com Follow us on Twitter: @ifsworld. Visit the IFS Blogs on technology, innovation, and creativity: blogs.ifsworld.com IFS discloses the information provided herein pursuant to the Financial Instruments Trading Act (1991:980) and/or the Securities Markets Act (2007:528). The information was submitted for publication on July 31, 2013 at 6:00 p.m. (CEST). Contact Information Mark Boulton Telefon: 44 1494 428900 Chief Marketing Officer press@ifsworld.com (mark.boulton@ifsworld.com) Frédéric Guigues Telefon: 46 8 58 78 45 00 Investor Relations frederic.guigues@ifsworld.com
Change in the total number of shares and votes in IFS
Top 10 Most Recent News Articles
The Real Cost of Cabinet Decisions: Refinish or Replace?
Uncovering the Truth Behind Cabinet Decisions When it comes to sprucing up a kitchen, most folks overlook what's hanging on their walls already: those tired old cabinets. Now, are you looking at chucking them out the window for brand-new ones, or can a fresh coat of paint breathe new life into them? Well, that's where Melvin Jones, a painting virtuoso from Lexington,...
Continue Reading
Govee Stirs Halloween Chills with New Sarah Gellar Ad
Lighting Up Halloween the Hollywood Way When it comes to Halloween, folks go nuts driving up the thrill factor at home, and boy, has Govee nailed it this time around. They've dragged Sarah Michelle Gellar into their spooky mix, transforming homes into eerie masterpieces. And let's face it, who better than the 'Buffy the Vampire Slayer' herself to stir those spine-tingling...
Continue Reading
Aetna's 2027 Medicare Plans: Comprehensive Outlook
Unpacking Aetna's Medicare Strategy for 2027 Look, if there's one thing you should keep tabs on, it's how Aetna isn't just coasting by in the healthcare arena. These folks are pushing forward with new options for 2027 that prove they're serious about making healthcare not just accessible, but affordable across the board. Aetna, backed by CVS Health (NYSE: CVS), is making...
Continue Reading
Vatrer Power: Lithium Batteries Revolutionize Golf Carts
The humdrum world of golf carts just got a jolt of energy with lithium batteries entering the fray. Vatrer Power, the brain behind some nifty LiFePO4 lithium battery conversions, made some noise at this year's Golf Carting Expo & Dealer Summit in Charleston, South Carolina. Held at the North Charleston Convention Center, this trade show was the industry's premier...
Continue Reading
Kal Plastics Showcases at Design-2-Part Expo
Kal Plastics Steps into the Limelight There's a buzz in the air, and it's all about Kal Plastics getting ready to strut their stuff at the Southern California Design-2-Part Show. Now, most folks probably don't spend their nights dreaming about thermoforming and pressure forming, but these guys sure make a case for it. They’ve got their eyes on impressing the crowd with...
Continue Reading
Venice's Climate Challenge: Rising Seas, Sinking Lands
Sea Rise Isn’t Just a Statistics Problem The ordeal of rising seas isn't just about staring at numbers in some spreadsheet, it's a real-world gut punch that's knocking at Venice's door. This city, known for its stunning architecture and winding canals, now serves as the poster child for what happens when Mother Nature and human errors leave a place on the brink of...
Continue Reading
Ractigen's Breakthrough in DMD: RNA Activates Utrophin
Ractigen's New Fight Against Duchenne: A Personal Take When it comes to biotech advancements, I've seen enough breakthroughs to not get swayed easily. But Ractigen Therapeutics presenting their first-in-human data on RNA activation for Duchenne Muscular Dystrophy (DMD) kind of demands your attention. Folks, they're talking about a potential shift in handling this brutal...
Continue Reading
Trading Platforms Poised for Billions by 2031
Forecasts and Fierce Digital Landscapes Just when you thought the online trading realm was getting saturated, the numbers are making it clear: there’s still room for growth—even explosive growth. The online trading platform market is eyeing a hike, jumping from a $11.65 billion valuation in 2025 to a projected $18.18 billion by 2031, according to Mordor Intelligence....
Continue Reading
Honeywell's Supply Line Snags Bait Class Action Risk
Stepping into the chaos of the stock market sometimes feels like opening Pandora's box—just when you think you've seen it all, something new tumbles out. This time around, it's Honeywell Aerospace (NasdaqGS: HONA) playing catch with hot coals, and a burning class-action lawsuit smolders in the air. Deadline Looms for Investors in Class Action Heads up, folks! If you've...
Continue ReadingTop 5 Most Recently Viewed Articles
Sanoma Corporation Boosts Shareholders with Recent Buyback
Sanoma Corporation's Share Buyback Initiative Sanoma Corporation is actively demonstrating its commitment to enhancing shareholder value through a recent buyback of its own shares. This strategic move signals confidence in its operational health and future growth prospects, making it an exciting time for investors. Details of the Share Acquisition The share buyback...
Continue Reading
Geotab Strengthens Fleet Sustainability with New Tools
Innovative Sustainability Solutions from Geotab In the ever-evolving landscape of fleet management, sustainability has become a critical focus, especially in the fight against climate change. Geotab Inc., a leader in connected transportation solutions, has taken a significant step forward by launching a comprehensive suite of sustainability tools designed to help...
Continue Reading
Southwest Airlines Surpasses Quarterly Earnings Expectations
Southwest Airlines Achieves Impressive Q3 Growth Southwest Airlines Co (NYSE: LUV) has reported a remarkable increase in its operating revenue for the third quarter, rising by 5.3% year-over-year to reach a total of $6.870 billion. This figure surpassed market expectations, which were set at $6.735 billion, signaling a strong performance amidst industry challenges....
Continue Reading
Exploring the Growth of Blockchain in Healthcare to $90.52 Billion
Blockchain Technology Transforming the Healthcare Market The global healthcare market for blockchain technology is set for remarkable growth, with forecasts showing an increase from USD 2.84 billion in 2023 to an impressive USD 90.52 billion by 2033. This substantial growth, which represents a Compound Annual Growth Rate (CAGR) of 41.37%, underscores the rising adoption...
Continue Reading
GeneCentric's Groundbreaking Insights on Bladder Cancer Treatment
GeneCentric Therapeutics dropped a bombshell with its GARNER study on bladder cancer back in 2024. This wasn't just another research initiative; it was the biggest cohort focused on high-risk non-muscle invasive bladder cancer (HR-NMIBC), aiming to reshape how we understand and treat this tough nut. GARNER Study: A Game Changer? The GARNER study stood out as a monumental...
Continue Reading